Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes

Impact of switching from neutral protamine hagedorn insulin (NPH) to glargine insulin on glycemic control and clinical outcomes in pediatric patients with type 1 diabetes

Background: Treatment of type 1 diabetes requires insulin therapy, and various types of insulin can be used. Insulin glargine has been shown to provide effective glycemic control with reduced hypoglycemia. However, there are no prior studies investigating the effects of switching from neutral protam...

Full description

Saved in:
Bibliographic Details
Main Authors: Hiba Abdelmunim Suliman Elsheikh, Safaa Badi, Ahmed Hafiz Kamal, Mazen Karar, Mohamed Fouad, Omar Khalid, Omnia Abdullah, Setana Mamoun
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Exploratory Research in Clinical and Social Pharmacy
Subjects:
Diabetes mellitus type 1
Fasting blood glucose
Glycosylated hemoglobin
HbA1c
Neutral protamine Hagedorn
Glargine insulin
Online Access:http://www.sciencedirect.com/science/article/pii/S2667276625000538
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items